葡萄京娱乐场网上平台网站_入口

葡萄京娱乐场网上平台网站

News

To standardize management, management to promote efficiency, efficiency to promote innovation,
innovation and innovation to innovation and development.
Shandong Xinchuang biological Co., Ltd. was awarded as "top 10 independent innov
According to the requirements of the notice on the selection of "top 10", "top 10 independent innovation" and "top 10 leaders" of Shandong gazelle enterprises (Lu'an Ling Qi Chu Zi [2019] No. 3), our company was finally awarded the "independent" of Shandong gazelle enterprises after the experts' preliminary examination, online public voting and expert final review organized by the provincial gazelle Enterprise Development Promotion Association and the provincial brand building Promotion Association Top 10 innovation.
Shandong Xinchuang biology is mainly engaged in the research and development of biotechnology. At present, it is mainly engaged in the research and development of new anti-tumor drugs of oncolytic bacteria; at the same time, it also carries out research on tumor cell therapy, stem cell and regenerative medicine, accurate diagnosis, etc. After long-term unremitting efforts and dedicated management, the comprehensive strength is constantly enhanced, and the enterprise brand continues to improve. Especially in recent years, through continuous technological innovation and management innovation, the company has stepped into a fast track. The company has been awarded the following 100 most successful Awards: Shandong high-tech enterprise, Shandong gazelle enterprise, Shandong Xinchuang biological academician expert workstation, Jinan tumor biological immune technology engineering laboratory, Jinan post doctoral innovation practice workstation, and Chinese overseas students entrepreneurship Park Long term enterprise, Jinan specialized special new small and medium-sized enterprises and other honorary titles.
At present, the main R & D projects are as follows:
1. Oncolytic bacterial drugs (a class of new biological drugs, which have entered the approval process of clinical trials)
2. Tumor cell therapy (NK, DC, car-t, CTL, etc., in clinical trials)
3. Stem cells and regenerative medicine (Research on the treatment of multiple diseases with autologous adipose derived mesenchymal stem cells and umbilical cord mesenchymal stem cells, and several batches of products have been prepared and frozen)
4. Accurate diagnosis (3 diagnostic kit products, sorting materials, preparing to apply for medical device registration certificate)
(1) Early diagnosis kit for Alzheimer's disease
(2) Padi2, PADI4 multiple ELISA kit for early diagnosis of tumor
(3) Diagnostic kit for minimal residual disease of leukemia
With its excellent R & D team, advanced scientific research equipment, abundant R & D achievements, strict quality control system, standardized experimental facilities, perfect management mechanism, innovative cultural concept, sincere partners and employee protection of rights and interests, the company has a strong strength in the field of biological new drug technology research and development, which is widely recognized by all walks of life.
The award of "top 10 independent innovation" of Shandong gazelle enterprises is an affirmation of the company's past independent innovation achievements. We will take this as a new starting point, constantly improve the level of scientific and technological innovation, and make contributions to the realization of the Chinese people's health and well-being and healthy China!
Appendix: approval document of Shandong gazelle top 10 independent innovation enterprises
Copyright © 2020 Shandong Xinchuang Biotechnology Co., Ltd. All Rights Reserved
Baidu
sogou